Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake.

Autor: Mukand NH; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA., Chirikova E; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA., Lichtensztajn D; Greater Bay Area Cancer Registry, University of California San Francisco, San Francisco, California, USA., Negoita S; Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, USA., Aboushwareb T; Pacific Edge Limited, Dunedin, New Zealand., Bennett J; Exact Sciences, Redwood City, California, USA., Brooks JD; Department of Urology, Stanford Medicine, Palo Alto, California, USA., Leppert JT; Department of Urology, Stanford Medicine, Palo Alto, California, USA., Chung BI; Department of Urology, Stanford Medicine, Palo Alto, California, USA., Li C; Cancer Surveillance System, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Schwartz SM; Cancer Surveillance System, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Gershman ST; Massachusetts Department of Public Health, Boston, Massachusetts, USA., Insaf T; Bureau of Cancer Epidemiology, New York State Health Department, Albany, New York, USA.; School of Public Health, Epidemiology and Biostatistics, University of Albany, Albany, New York, USA., Morawski BM; Cancer Data Registry of Idaho, Boise, Idaho, USA., Stroup A; New Jersey Cancer Registry, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Biostatistics and Epidemiology, Rutgers School of Public Health, New Brunswick, New Jersey, USA., Wu XC; Louisiana Tumor Registry, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA., Doherty JA; Utah Cancer Registry, University of Utah, Salt Lake City, Utah, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA., Petkov VI; Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, USA., Zambon JP; MDxHealth, Irvine, California, USA., Gomez SL; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.; Greater Bay Area Cancer Registry, University of California San Francisco, San Francisco, California, USA.; Cancer Surveillance System, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Cheng I; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.; Greater Bay Area Cancer Registry, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.

Publikováno v: Cancer [Cancer] 2024 Dec 15; Vol. 130 (24), pp. 4298-4305. Date of Electronic Publication: 2024 Aug 19.

The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer.

Autor: Helfand BT; NorthShore University HealthSystem, Evanston, Illinois, United States of America., Paterakos M; NorthShore University HealthSystem, Evanston, Illinois, United States of America., Wang CH; NorthShore University HealthSystem, Evanston, Illinois, United States of America., Talaty P; NorthShore University HealthSystem, Evanston, Illinois, United States of America., Abran J; Exact Sciences Corporation, Madison, Wisconsin, United States of America., Bennett J; Exact Sciences Corporation, Madison, Wisconsin, United States of America., Hall DW; Exact Sciences Corporation, Madison, Wisconsin, United States of America., Lehman A; Exact Sciences Corporation, Madison, Wisconsin, United States of America., Aboushwareb T; Exact Sciences Corporation, Madison, Wisconsin, United States of America.

Publikováno v: PloS one [PLoS One] 2022 Sep 01; Vol. 17 (9), pp. e0273782. Date of Electronic Publication: 2022 Sep 01 (Print Publication: 2022).

Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy.

Autor: Brooks MA; Scott Department of Urology, Baylor College of Medicine, Houston, TX., Thomas L; Division of Urologic Surgery, Washington University in St. Louis, St. Louis, MO., Magi-Galluzzi C; Department of Anatomic Pathology, University of Alabama Birmingham, Birmingham, AL., Li J; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH., Crager MR; Exact Sciences Corporation, Redwood City, CA., Lu R; Exact Sciences Corporation, Redwood City, CA., Baehner FL; Exact Sciences Corporation, Redwood City, CA., Abran J; Exact Sciences Corporation, Redwood City, CA., Aboushwareb T; Exact Sciences Corporation, Redwood City, CA., Klein EA; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. Electronic address: Kleine@ccf.org.

Publikováno v: Urologic oncology [Urol Oncol] 2022 Mar; Vol. 40 (3), pp. 104.e1-104.e7. Date of Electronic Publication: 2021 Nov 23.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The 17-Gene Genomic Prostate Score Test as a Predictor of Outcomes in Men with Unfavorable Intermediate Risk Prostate Cancer.

Autor: Cullen J; Cancer Population Sciences, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH. Electronic address: jxc1650@case.edu., Kuo HC; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of Health Sciences, Bethesda, MD; Henry M. Jackson Foundation, Bethesda, MD., Shan J; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Lu R; Genomic Health Inc., an Exact Sciences Corporation, Redwood City, CA., Aboushwareb T; Genomic Health Inc., an Exact Sciences Corporation, Redwood City, CA., Van Den Eeden SK; Division of Research, Kaiser Permanente Northern California, Oakland, CA.

Publikováno v: Urology [Urology] 2020 Sep; Vol. 143, pp. 103-111. Date of Electronic Publication: 2020 Jun 07.